NeueHealth (NEUE) to Release Quarterly Earnings on Thursday

NeueHealth (NYSE:NEUE) is expected to be announcing its earnings results before the market opens on Thursday, March 20th. Analysts expect the company to announce earnings of ($2.29) per share and revenue of $261.80 million for the quarter. Investors interested in listening to the company’s conference call can do so using this link.

NeueHealth Stock Performance

NeueHealth stock opened at $5.10 on Wednesday. The business’s 50-day simple moving average is $7.16 and its 200-day simple moving average is $6.01. The firm has a market capitalization of $42.25 million, a PE ratio of -0.10 and a beta of 0.56. NeueHealth has a 52 week low of $3.79 and a 52 week high of $7.66.

Insider Buying and Selling

In other NeueHealth news, CFO Jay Matushak sold 4,448 shares of NeueHealth stock in a transaction that occurred on Thursday, March 13th. The stock was sold at an average price of $6.74, for a total transaction of $29,979.52. Following the sale, the chief financial officer now directly owns 41,592 shares of the company’s stock, valued at approximately $280,330.08. The trade was a 9.66 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO George Lawrence Mikan III sold 12,440 shares of the business’s stock in a transaction that occurred on Friday, March 14th. The stock was sold at an average price of $6.13, for a total value of $76,257.20. Following the completion of the transaction, the chief executive officer now directly owns 249,454 shares in the company, valued at $1,529,153.02. The trade was a 4.75 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 110,033 shares of company stock valued at $774,560 over the last three months. 64.30% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

Separately, Royal Bank of Canada dropped their price objective on NeueHealth from $8.00 to $7.00 and set a “sector perform” rating on the stock in a research note on Monday, December 9th.

About NeueHealth

NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.